The SGLT2 inhibitor empagliflozin for the treatment of type 2 diabetes mellitus: A bench to bedside review

Authors

Janet B. McGill, Washington University School of Medicine in St. Louis

Journal

Diabetes Therapy

Publication Date

2014

Volume

5

Issue

1

Inclusive Pages

43-63

Document Type

Open Access Publication

DOI

10.1007/s13300-014-0063-1

Rights and Permissions

McGill, J.B. Diabetes Ther (2014) 5: 43. https://doi.org/10.1007/s13300-014-0063-1 This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Recommended Citation

McGill, Janet B., "The SGLT2 inhibitor empagliflozin for the treatment of type 2 diabetes mellitus: A bench to bedside review." Diabetes Therapy. 5, 1. 43-63. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/6186